| Status: | Phase 1 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | QWZ40O5W6K |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Carcinoma, Transitional Cell; Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1/Phase 2 | ClinicalTrials |
| Urinary Bladder Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 1 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1188450-53-4 |
| ChEMBL | CHEMBL4297689 |
| FDA SRS | QWZ40O5W6K |
CONTENTS